Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CC-98633 |
Synonyms | |
Therapy Description |
CC-98633 are T-lymphocytes engineered to express chimeric antigen receptor (CAR) that targets B-cell maturation antigen (BCMA; TNFRSF17), potentially resulting in enhanced cytokine production and antitumor activity (Blood (2022) 140 (Supplement 1): 1360-1362). |